Vanda Pharmaceuticals: Q3 Earnings Insights

Vanda Pharmaceuticals VNDA reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Vanda Pharmaceuticals their estimated earnings by 12.5%, reporting an EPS of $0.14 versus an estimate of $0.16, which surprised analysts.

Revenue was up $9,787,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03, which was followed by a 8.5% drop in the share price the next day.

Here's a look at Vanda Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.